Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Flow Cytometric Assessment of FcγRIIIa-V158F Polymorphisms and NK Cell Mediated ADCC Revealed Reduced NK Cell Functionality in Colorectal Cancer Patients.
Schiele P, Kolling S, Rosnev S, Junkuhn C, Walter AL, von Einem JC, Stintzing S, Schöning W, Sauer IM, Modest DP, Heinrich K, Weiss L, Heinemann V, Bullinger L, Frentsch M, Na IK. Schiele P, et al. Among authors: heinemann v. Cells. 2024 Dec 31;14(1):32. doi: 10.3390/cells14010032. Cells. 2024. PMID: 39791733
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6 + tucatinib + trastuzumab for HER2+ metastatic colorectal cancer.
Strickler JH, Bekaii-Saab T, Cercek A, Heinemann V, Nakamura Y, Raghav K, Siena S, Tabernero J, Van Cutsem E, Yoshino T, Ramos J, Guan X, Andre T. Strickler JH, et al. Among authors: heinemann v. Future Oncol. 2024 Dec 26:1-9. doi: 10.1080/14796694.2024.2441101. Online ahead of print. Future Oncol. 2024. PMID: 39723627 Free article.
Tumor-intrinsic kinome landscape of pancreatic cancer reveals new therapeutic approaches.
Xu Y, Peng XL, East MP, McCabe IC, Stroman GC, Jenner MR, Chan PS, Morrison AB, Shen EC, Hererra SG, Joisa CU, Rashid NU, Iuga AC, Gomez SM, Miller-Phillips L, Boeck S, Heinemann V, Haas M, Ormanns S, Johnson GL, Yeh JJ. Xu Y, et al. Among authors: heinemann v. Cancer Discov. 2024 Dec 5. doi: 10.1158/2159-8290.CD-23-1480. Online ahead of print. Cancer Discov. 2024. PMID: 39632628
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer-results from the FIRE-4.5 study.
Klein-Scory S, Baraniskin A, Schmiegel W, Mika T, Schroers R, Held S, Heinrich K, Tougeron D, Modest DP, Schwaner I, Eucker J, Pihusch R, Stauch M, Kaiser F, Kahl C, Karthaus M, Müller C, Burkart C, Stintzing S, Heinemann V. Klein-Scory S, et al. Among authors: heinemann v. Mol Oncol. 2024 Dec 4. doi: 10.1002/1878-0261.13778. Online ahead of print. Mol Oncol. 2024. PMID: 39630848 Free article.
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer.
Andre T, Elez E, Van Cutsem E, Jensen LH, Bennouna J, Mendez G, Schenker M, de la Fouchardiere C, Limon ML, Yoshino T, Li J, Lenz HJ, Manzano Mozo JL, Tortora G, Garcia-Carbonero R, Dahan L, Chalabi M, Joshi R, Goekkurt E, Braghiroli MI, Cil T, Cela E, Chen T, Lei M, Dixon M, Abdullaev S, Lonardi S; CheckMate 8HW Investigators. Andre T, et al. N Engl J Med. 2024 Nov 28;391(21):2014-2026. doi: 10.1056/NEJMoa2402141. N Engl J Med. 2024. PMID: 39602630 Clinical Trial.
Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.
Tüshaus J, Eckert S, Schliemann M, Zhou Y, Pfeiffer P, Halves C, Fusco F, Weigel J, Hönikl L, Butenschön V, Todorova R, Rauert-Wunderlich H, The M, Rosenwald A, Heinemann V, Holch J, Steiger K, Delbridge C, Meyer B, Weichert W, Mogler C, Kuhn PH, Kuster B. Tüshaus J, et al. Among authors: heinemann v. EMBO J. 2025 Jan;44(1):304-329. doi: 10.1038/s44318-024-00289-w. Epub 2024 Nov 18. EMBO J. 2025. PMID: 39558110 Free PMC article.
Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552].
Hartlapp I, Valta-Seufzer D, Siveke JT, Algül H, Goekkurt E, Siegler G, Martens UM, Waldschmidt D, Pelzer U, Fuchs M, Kullmann F, Boeck S, Ettrich TJ, Held S, Keller R, Anger F, Germer CT, Stang A, Kimmel B, Heinemann V, Kunzmann V; German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators. Hartlapp I, et al. Among authors: heinemann v. ESMO Open. 2024 Oct;9(10):103705. doi: 10.1016/j.esmoop.2024.103705. Epub 2024 Aug 29. ESMO Open. 2024. PMID: 39461776 Free PMC article. No abstract available.
Bridging the gap: Leveraging telemedicine and IT infrastructure to connect outpatient oncology practices with specialized expert teams in the management of rare tumors.
Kasprzak J, Goering T, Berger-Thürmel K, Kratzer V, Prompinit W, Wichert SP, Leutner S, Langermann N, von Bergwelt-Baildon M, Heinemann V, Algül H, Zünkeler M, Nasseh D; TARGET Group *. Kasprzak J, et al. Among authors: heinemann v. Digit Health. 2024 Oct 9;10:20552076241272709. doi: 10.1177/20552076241272709. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 39398892 Free PMC article.
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1.
Seufferlein T, Mayerle J, Boeck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. Seufferlein T, et al. Among authors: heinemann v. Z Gastroenterol. 2024 Oct;62(10):1724-1785. doi: 10.1055/a-2338-3716. Epub 2024 Oct 10. Z Gastroenterol. 2024. PMID: 39389105 Free article. German. No abstract available.
S3-Leitlinie Exokrines Pankreaskarzinom – Version 3.1.
Seufferlein T, Mayerle J, Boeck S, Brunner T, Ettrich TJ, Grenacher L, Gress TM, Hackert T, Heinemann V, Kestler A, Sinn M, Tannapfel A, Wedding U, Uhl W. Seufferlein T, et al. Among authors: heinemann v. Z Gastroenterol. 2024 Oct;62(10):e874-e995. doi: 10.1055/a-2338-3533. Epub 2024 Oct 10. Z Gastroenterol. 2024. PMID: 39389103 Free article. German. No abstract available.
582 results